KALV kalvista.com: Accounting Value per Share
KalVista Pharmaceuticals (KALV) ensures the seamless delivery of orphan drugs through a global warehouse network, guaranteeing high profitability. Management is currently focusing on bringing its lead product to market, leveraging investor confidence following successful trials. This price chart illustrating value trends reflects the price action of an asset whose success depends on medicine rather than economic cycles, with the -0.38 metric.
kalvista.com - analytical breakdowns and key metrics (KALV)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Total Debt to Capital KalVista Pharmaceuticals|KALV - Long-Term Debt to Capital|Short-Term Debt to Equity KalVista Pharmaceuticals, Inc.|KALV - Aggregate Debt Obligations|Debt to Book Capitalization Ratio KalVista Pharmaceuticals, Inc.|KALV - Company Long-Term Liabilities|Company Short-Term Debts KalVista Pharmaceuticals
Fundamental company valuation:KalVista Pharmaceuticals Inc - KALV
Investments in the R&D core of KalVista Pharmaceuticals and the hiring of commercialization experts are reflected in the dynamics demonstrated by the published book value per share. This indicator determines the business's asset backing by dividing total shareholders' equity by the number of issued shares. The current value of -0.38 captures the net asset value per share. The growth of this metric confirms the capitalization of the company's internal resources, while a stable trend indicates a resilient financial foundation.
Competitors of KalVista Pharmaceuticals (KALV)
ARGX - Net Assets per Single Share|BioNTech Pharma (BNTX) - Net Assets per Single Share|Abivax Corp (ABVX) - Accounting Value per Share|ADMA (admabiologics.com) - Net Assets per Single Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|SEPN (Septerna Corp) - Accounting Value per Share|Book Value per Share PVLA|Net Assets per Single Share Savara Inc. SVRA|Equity per Share rigel.com (RIGL)|ANAB: Book Value per Share|Astria Therapeutics Inc - Net Asset Value per Share|enGene Bio - Net Assets per Single Share|RAPT - Book Value per Share|JBIO: Book Value per Share|ACRS (aclaristx.com) - Book Value per Share|Net Assets per Single Share Kyverna Therapeutics, Inc.|Net Assets per Single Share Tiziana Life Sciences Ltd. (TLSA)|Accounting Value per Share Cabaletta Bio, Inc (CABA)|Net Assets per Single Share Ventyx Biosciences, Inc (VTYX)|Book Value per Share THTX|avalotx.com - Net Assets per Share|Net Assets per Single Share ELDN (Eledon Pharmaceuticals, Inc.)|Agenus, Inc. (AGEN) - Net Assets per Share|CLYM - Accounting Value per Share|Zura Bio Ltd (ZURA) - Book Price of a Share|ATYR (aTyr Pharma, Inc.) - Book Value per Share|Book Value per Share Adagene Corp (ADAG)|ImageneBio Inc (IMA) - Accounting Value per Share|Accounting Value of a Share STTK (shattucklabs.com)|Equillium (EQ) - Net Assets per Single Share|Share Book Value Connect Biopharma Holdings CNTB|Book Value per Share Immunic Inc (IMUX)|ATRA - Accounting Value of a Share|IFRX: Book Value per Share|XFOR (X4 Pharmaceuticals Inc.) - Book Value per Share|ACET - Net Assets per Single Share|Accounting Value of a Share CELU|Net Assets per Single Share INMB (INmune Bio, Inc.)|Accounting Value per Share barinthusbio.com (BRNS)|Book Value per Share KZR (Kezar Life Sciences, Inc.)|Book Value per Share SAB Biotherapeutics Inc. SABS|AKTX: Book Value per Share|ENLV - Accounting Value per Share|Book Value per Share QTTB|Net Asset Value per Share geovax.com|EDSA (Edesa Biotech) - Accounting Value per Share|Book Value per Share iBio Inc (IBIO)|Accounting Value per Share Carisma Therapeutics|Book Price of a Share XTL Bio (XTLB)|Book Value per Share BOLT|Net Assets per Share HCW Biologics, Inc. HCWB|APVO: Book Value per Share|AIM - Accounting Value per Share|ADTX: Book Value per Share|GRI (GRI Bio Corporation) - Book Value per Share|Net Assets per Single Share XORTX Therapeutics Inc.|Net Assets per Single Share HIND|REVB (Revelation Biosciences, Inc.) - Net Assets per Single Share|Net Assets per Share INDP (Indaptus Therapeutics Inc)|Net Assets per Single Share SCNI (Scinai)|Book Value per Share CalciMedica Inc CALI|Affimed Therapeutics - Book Value per Share|ALLK: Book Value per Share|hookipapharma.com (HOOK) - Net Assets per Single Share|Net Assets per Single Share IGM Biosciences|Accounting Value per Share iTeos|Net Assets per Single Share OCEA|TCBP - Net Assets per Single Share|Share Book Value thirdharmonicbio.com (THRD)